OpenADMET competition: bigger AI models not always better for drug metabolism

Results from the OpenADMET competition indicate that larger AI models do not consistently outperform smaller ones in predicting drug metabolism. This finding challenges the prevailing assumption that scale always improves performance in biomedical AI.
1 source
Daily brief
Get tomorrow's AI brief in your inbox
More stories today
- Uber builds uReview, a multi-agent code review engine
- Mistral shows how to build HTML5 games with agents
- YouTube restricts views of AI music, Suno users report
- Defining an AI Kill Switch Is Hard, But Necessary
- AI-driven hiring freeze leaves job seekers rejected